Medical Supplies for Continuous Blood Glucose Monitoring Systems

This contract involves the supply of medical consumables for continuous blood glucose monitoring systems, specifically for Lot 1 (Type 1 Sensors) and Lot 2 (Type 2 Sensors). The minimum and maximum quantities are detailed in the specifications document. Subsequent contracts will be established based on the framework agreement, depending on the allocated budget. The largest subsequent contract is expected to be monthly or for any period covered by the available budget. The products are part of the National Diabetes Program, which is managed according to the technical norms attached to Order 180/2022 by the President of CNAS. The minimum and maximum quantities for the framework agreement and subsequent contracts are specified in the specifications document and in Section II.1.6) Division into lots. - LOT 1 CONSUMABLE MATERIALS for continuous blood glucose monitoring systems (subcutaneous implantable biosensor with built-in transmitter and insertion system) – TYPE 1 SENSORS related to the specific device in the initiation set: Estimated minimum value of the framework agreement: 14,999,100.00 lei excluding VAT; Estimated maximum value of the framework agreement: 23,528,000.00 lei excluding VAT; Estimated minimum value of the subsequent contract: 294.10 lei excluding VAT; Estimated maximum value of the subsequent contract: 970,530.00 lei excluding VAT; - LOT 2 CONSUMABLE MATERIALS for continuous blood glucose monitoring systems (subcutaneous implantable biosensor with built-in transmitter and insertion system) – TYPE 2 SENSORS related to the specific device in the initiation set: Estimated minimum value of the framework agreement: 19,956,800.00 lei excluding VAT; Estimated maximum value of the framework agreement: 24,946,000.00 lei excluding VAT; Estimated minimum value of the subsequent contract: 249.46 lei excluding VAT; Estimated maximum value of the subsequent contract: 1,022,786.00 lei excluding VAT.